IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2
IMM-BCP-01 是一种患者来源的抗 SARS-CoV-2 抗体混合物，对包括 Omicron BA.1 和 BA.2 在内的受关注变体均有效
期刊:Science Immunology
影响因子:17.6
doi:10.1126/sciimmunol.abl9943
Pavel A Nikitin, Jillian M DiMuzio, John P Dowling, Nirja B Patel, Jamie L Bingaman-Steele, Baron C Heimbach, Noeleya Henriquez, Chris Nicolescu, Antonio Polley, Eden L Sikorski, Raymond J Howanski, Mitchell Nath, Halley Shukla, Suzanne M Scheaffer, James P Finn, Li-Fang Liang, Todd Smith, Nadia Sto
